Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S. Kolks"'
Autor:
Siegfried Seeber, G Stüben, L. Schlenger, Michael Stahl, Jochen Schütte, Volker Budach, D. Greschuchna, M. Stuschke, H Sack, S. Kolks, M R Müller, Wilfried Eberhardt, M Flasshove, Hansjochen Wilke, H. Teschler, Georgios Stamatis
Publikováno v:
British Journal of Cancer
Following mediastinoscopy, a prognostically orientated multimodality approach was chosen in selected small-cell lung cancer (SCLC) patients with hyperfractionated accelerated chemoradiotherapy (Hf-RTx) and definitive surgery (S). Stage IB/IIA patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecf7b31ba5ee083eb79089342cc59ea2
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/92149
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/92149
Autor:
D. Greschuchna, A. Harstrick, S. Kolks, Siegfried Seeber, M. Stahl, M Flasshove, H. Wilke, Martin Stuschke, Wilfried Eberhardt, N. Konietzko, U. Klassen, M.R. Mueller, Georgios Stamatis
Publikováno v:
Lung Cancer. 18:61
Autor:
U. Fuths, Michael Stahl, D. Greschuhna, A. Haarstrik, N. Konietzko, Siegfried Seeber, M.R. Nowrouslen, S. Kolks, Hansjochen Wilke, M.R. Müller, L. Schlenger, Martin Stuschke, Georgios Stamatis, Wilfried Eberhardt, U. Klaassen
Publikováno v:
European Journal of Cancer. 31:S19
Since 6/91, 38 patients (pts) with limited disease SCLC (mediastinoscopy obligatory) have been entered into this ongoing trial. Pts with stage, I and II were treated with 4 cycles cisplatin (50 mg/m 2 d 1 + 7) and etoposide (170 mg/m 2 d 3, 4, 5) = P
Autor:
Eberhardt W; Department of Internal Medicine (Cancer Research), West German Cancer Center, University of Essen Medical School. Wilfried.eberhardt@uni-essen.de, Stamatis G, Stuschke M, Wilke H, Müller MR, Kolks S, Flasshove M, Schütte J, Stahl M, Schlenger L, Budach V, Greschuchna D, Stüben G, Teschler H, Sack H, Seeber S
Publikováno v:
British journal of cancer [Br J Cancer] 1999 Dec; Vol. 81 (7), pp. 1206-12.